Exponent (NASDAQ:EXPO) Issues Earnings Results, Beats Expectations By $0.13 EPS

Exponent (NASDAQ:EXPO - Get Free Report) issued its quarterly earnings data on Thursday. The business services provider reported $0.59 EPS for the quarter, beating the consensus estimate of $0.46 by $0.13, Briefing.com reports. Exponent had a return on equity of 28.49% and a net margin of 18.69%. The firm had revenue of $137.21 million during the quarter, compared to analyst estimates of $125.98 million. During the same quarter in the prior year, the business posted $0.56 EPS. The business's revenue for the quarter was up 6.6% compared to the same quarter last year.

Exponent Stock Performance

EXPO stock traded up $15.53 during midday trading on Friday, reaching $95.21. The stock had a trading volume of 997,220 shares, compared to its average volume of 312,451. The stock has a market cap of $4.82 billion, a PE ratio of 49.94 and a beta of 0.68. The firm has a fifty day simple moving average of $79.55 and a two-hundred day simple moving average of $81.92. Exponent has a 52-week low of $64.61 and a 52-week high of $102.72.

Exponent Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Investors of record on Friday, March 8th were paid a $0.28 dividend. This is a positive change from Exponent's previous quarterly dividend of $0.26. The ex-dividend date was Thursday, March 7th. This represents a $1.12 dividend on an annualized basis and a yield of 1.18%. Exponent's dividend payout ratio (DPR) is 57.44%.

Insider Buying and Selling

In other Exponent news, insider Eric Guyer sold 3,367 shares of the stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $78.49, for a total transaction of $264,275.83. The sale was disclosed in a filing with the SEC, which is available through this link. 2.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on EXPO. Truist Financial decreased their price objective on Exponent from $110.00 to $95.00 and set a "buy" rating for the company in a report on Friday, February 2nd. StockNews.com upgraded Exponent from a "sell" rating to a "hold" rating in a report on Monday, March 4th.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.